NovoCure NVCR Foreign currency remeasurement (loss) gain on debt
Foreign currency remeasurement (loss) gain on debt at other companies
Other financials
Where this comes from
Reported directly by NovoCure in its filing.
Tagged under the XBRL concept us-gaap:ForeignCurrencyTransactionGainLossBeforeTax.
The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about NovoCure's foreign currency remeasurement (loss) gain on debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is NovoCure's foreign currency remeasurement (loss) gain on debt?
- NovoCure (NVCR) reported foreign currency remeasurement (loss) gain on debt of -$477K in Q1 2026.
- How has NovoCure's foreign currency remeasurement (loss) gain on debt changed year-over-year?
- NovoCure's foreign currency remeasurement (loss) gain on debt decreased by 1073.5% year-over-year, from $49K to -$477K.
- What is the long-term trend for NovoCure's foreign currency remeasurement (loss) gain on debt?
- Over 2 years (2021 to 2024), NovoCure's foreign currency remeasurement (loss) gain on debt has grown at a -73.5% compound annual growth rate (CAGR), from -$3.23M to $227K.
- What does foreign currency remeasurement (loss) gain on debt mean?
- Represents the net realized and unrealized gains or losses resulting from fluctuations in exchange rates on transactions denominated in currencies other than the company's functional currency. This metric highlights the impact of global operational exposure on pre-tax earnings before accounting for tax effects. It serves as a key indicator of currency risk management effectiveness for companies with international revenue streams.